Change of Name

Recorded: 2014-02-03 Pages: 18

Assignor

CTI BIO

Executed: 2012-11-12

Assignee

OLIPASS CORPORATION

145 GWANGGYO-RO, YEONGTONG-GU, 4TH FLOOR, BUILDING A, AICT, GYEONGGI-DO, KOREA, REPUBLIC OF

Covered Properties (4)

Peptide Nucleic Acid Derivatives with Good Cell Penetration and Strong Affinity for Nucleic Acid

Patent: 8,680,253 →

Application: 12/922,322 →

Publication: US 2011/0178031

Peptide Nucleic Acid Derivatives with Good Cell Penetration and Strong Affinity for Nucleic Acid

Patent: 8,884,008 →

Application: 14/109,327 →

Publication: US 2014/0155604

Peptide Nucleic Acid Derivatives with Good Cell Penetration and Strong Affinity for Nucleic Acid

Patent: 8,859,766 →

Application: 14/133,045 →

Publication: US 2014/0155605

Peptide Nucleic Acid Derivatives with Good Cell Penetration and Strong Affinity for Nucleic Acid

Patent: 8,895,734 →

Application: 14/134,279 →

Publication: US 2014/0323728

Related Assignments (3)

Other recorded transfers of the patents in this record — the chain of ownership.